Showing results (4431-4440 of 27,716) with videos related to
Sort By:
Pageof 2,772
Vaccine|October 11, 2011
Immunization with the RTS,S/AS malaria vaccine induces IFN-γ(+)CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challengeRobert Schwenk, Joanne M Lumsden, Lisa E Rein, et al.Vaccine|October 11, 2011
Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in miceJoshua Tobias, Ann-Mari Svennerholm, Nils I A Carlin, et al.Vaccine|November 26, 2011
Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous doseScott A Halperin, David Scheifele, Gaston De Serres, et al.Vaccine|September 20, 2011
Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limitedSusan T Vadaparampil, Jessica A Kahn, Daniel Salmon, et al.Vaccine|December 31, 2011
Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigsHyun-Mi Pyo, Aleksandar Masic, Nizihti Woldeab, et al.Vaccine|March 17, 2012
Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreakRoxanne E Williams, Arlene C Sena, Anne C Moorman, et al.Vaccine|March 8, 2012
Health outcomes of interest for evaluation in the Post-Licensure Rapid Immunization Safety Monitoring ProgramTracy A Lieu, Michael D Nguyen, Robert Ball, et al.Vaccine|March 13, 2012
Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunityClaudia Gabriel, Sandra Blome, Alicia Urniza, et al.Vaccine|March 20, 2012
A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of ageRoger Baxter, Seth L Toback, Frangiscos Sifakis, et al.Pageof 2,772